# Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

> **NCT07243262** · — · RECRUITING · sponsor: **Imperial College London** · enrollment: 6079 (estimated)

## Conditions studied

- Pancreatic Cancer
- PDAC - Pancreatic Ductal Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Breath test

## Key facts

- **NCT ID:** NCT07243262
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2028-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 6079 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243262, "Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07243262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*